Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$48,640,916
-$4,395,383 QoQ
Shares Held
836,761
-8.3% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 329 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $14,161,458,348 across 17 Biotechnology names. PCVX ranks #14 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,490,637 | $9,681,584,117 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,750,699 | $2,935,252,919 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,504,387 | $200,521,024 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,344,701 | $199,197,006 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,621,890 | $185,236,528 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,532,303 | $170,131,602 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
1,388,881 | $159,262,984 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,686,625 | $143,683,583 |
All Filings in PCVX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,640,916 | 836,761 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $53,036,299 | 912,688 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $38,895,004 | 842,978 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $30,364,067 | 842,978 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $155,130,762 | 4,771,786 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $230,717,678 | 6,110,108 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $508,393,412 | 6,210,523 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $559,719,713 | 4,898,221 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $312,123,907 | 4,133,544 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $282,838,989 | 4,140,521 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $216,038,719 | 3,440,107 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $171,503,194 | 3,364,127 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $168,004,502 | 3,364,127 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $106,930,664 | 2,853,006 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $134,547,795 | 2,806,002 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,356,544 | 514,856 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||